What they were paid
RHYTHM PHARMACEUTICALS Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $60,000 | $299,966 | $300,015 | $0 | $659,981 |
| FY2024 | $60,000 | $165,560 | $398,782 | — | $624,342 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RHYTHM PHARMACEUTICALS, INC. DEF 14A filed April 29, 2026, accession 0001628280-26-028375, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025RHYTHM PHARMACEUTICALS pays directors a $50,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Nominating/Governance
The rest of the RHYTHM PHARMACEUTICALS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| David P. Meeker | Chair of the Board | $0 |
| David W. J. McGirr | Independent Director | $674,981 |
| Jennifer Good | Independent Director | $659,981 |
| Kimberly J. Popovits | Independent Director | $0 |
| Lynn A. Tetrault | Independent Director | $669,981 |
| Stuart A. Arbuckle | Independent Director | $659,981 |
The full RHYTHM PHARMACEUTICALS compensation record
free company briefThis page is one director within RHYTHM PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat